Dementia Atlas

Recent changes, record by record

Every record shows who last edited it. This page shows what changed: for each recent commit, the records it touched and the fields that differ, before and after. Read it to see the corpus being corrected and kept current, or to check a record you rely on.

200
Commits scanned
4827
Records touched
600
Changes in this feed
533
Field-level edits

Newest first, 548 records across 1 days. Additions list the fields the new record carries; edits show each changed field. Values are the source text, trimmed. Generated 2026-09-10 from the last 200 commits to src/data/.

2026-09-10

Sources: official-website links on every remaining companyJude Gomila067761977c
Sources: official-website links on thirty more companiesJude Gomilad37b709583
Tone pass: solution and mechanism first; frightening figures behind a clickJude Gomila28a6975696
  • FieldBeforeAfter
    history[ { year: 2000, title: "Molecular portraits define the basal-like subtype", note: "Perou and Sørlie's expression profiling separates basal-like from luminal breast cancers.", refs: ["rna-seq"] }, { year: 2...[ { year: 2000, title: "Molecular portraits define the basal-like subtype", note: "Perou and Sørlie's expression profiling separates basal-like from luminal breast cancers.", refs: ["rna-seq"] }, { year: 2...
  • FieldBeforeAfter
    history[ { year: 1987, title: "Slamon links HER2 amplification to poor prognosis" }, { year: 1998, title: "Trastuzumab approved", refs: ["trastuzumab"] }, { year: 2013, title: "First solid-tumour ADC: T-DM1...[ { year: 1987, title: "Slamon shows HER2 amplification marks aggressive disease, and a drug target" }, { year: 1998, title: "Trastuzumab approved", refs: ["trastuzumab"] }, { year: 2013, title: "Fir...
  • FieldBeforeAfter
    burden~85% of lung cancer; lung cancer kills ~1.8 million people a year, more than any other cancer."~85% of lung cancer. Low-dose CT screening catches cancers in people at high risk while they are still curable (NLST, NELSON), and a dozen targetable drivers each have a matched drug. Lung cancer still accounts for a...
    tldrNon-small-cell lung cancer is the biggest cancer killer, and the proving ground for precision medicine: a dozen targetable mutations, immunotherapy for the rest, and ADCs and bispecifics arriving now."Non-small-cell lung cancer is the proving ground for precision medicine: a dozen targetable mutations each with a matched pill, immunotherapy for the rest, and ADCs and bispecifics arriving now. Because most cases ar...
    stateOfArt["5-year PFS 60% with lorlatinib in ALK+ disease.", "Adjuvant osimertinib halves death risk.", "First regimen to beat osimertinib (MARIPOSA) and first to beat pembrolizumab (ivonescimab, China)."]["5-year PFS 60% with lorlatinib in ALK+ disease.", "Adjuvant osimertinib after surgery for EGFR-mutant disease roughly halves the risk of the cancer returning or of dying from it (ADAURA).", "First regimen to beat os...
  • FieldBeforeAfter
    burdenPancreatic cancer causes about 500,000 cases per year with 5-year survival of about 13%, and is projected to be the second-leading cancer killer in the US by 2030."Pancreatic cancer causes about 500,000 cases per year. Surgery followed by mFOLFIRINOX cures a meaningful share of the ~20% found early, high-risk surveillance now finds most cancers in carriers at stage I, and the f...
    tldrPancreatic cancer is the deadliest common cancer. Almost every tumour carries a KRAS mutation, and for the first time drugs against it are in pivotal trials."Almost every pancreatic tumour carries a KRAS mutation, and for the first time drugs against it work: daraxonrasib nearly doubled survival in previously treated disease in 2026. Pancreatic cancer has been the hardest...
  • FieldBeforeAfter
    openProblems["No effective screening.", "PARP resistance via BRCA reversion.", "Platinum-resistant disease remains lethal."]["No effective screening.", "PARP resistance via BRCA reversion.", "Platinum-resistant disease is the hardest setting; three drugs with survival benefit arrived in 2023-26 and each adds months, so combining and sequen...
  • FieldBeforeAfter
    burdenAbout 300,000 CNS tumours occur per year; glioblastoma median survival is about 15 months."About 300,000 CNS tumours occur per year, most of them not glioblastoma; IDH-mutant and paediatric low-grade gliomas can be lived with for decades and now have targeted drugs. Median survival for glioblastoma with ma...
    tldrGlioblastoma is the most lethal brain tumour, barely improved since 2005. Low-grade IDH-mutant gliomas, by contrast, got their first targeted drug in 2024."Gliomas are now diagnosed by molecular class, and three classes got their first targeted drugs in 2024-25 (vorasidenib for IDH-mutant glioma, tovorafenib for BRAF-altered paediatric glioma, dordaviprone for H3 K27M)....
    openProblems["Blood-brain barrier.", "Immunologically cold, heterogeneous, infiltrative.", "No progress in glioblastoma survival in 20 years."]["Blood-brain barrier.", "Immunologically cold, heterogeneous, infiltrative.", "Glioblastoma: no systemic drug has beaten the 2005 standard; getting drugs across the blood-brain barrier is the crux."]
  • FieldBeforeAfter
    openProblems["Overdiagnosis of microcarcinoma.", "Anaplastic thyroid cancer remains lethal."]["Overdiagnosis of microcarcinoma.", "Anaplastic thyroid cancer: BRAF V600E cases now respond to dabrafenib-trametinib, often enough to allow surgery; the 60% without the mutation still have few options."]
  • FieldBeforeAfter
    openProblems["TP53-mutant AML remains lethal.", "Older patients."]["TP53-mutant AML: no drug class has yet improved survival, so it is the priority for new mechanisms.", "Older patients."]
  • FieldBeforeAfter
    openProblems["Indefinite BTKi therapy: cost, toxicity and resistance (BTK C481S).", "CXCR4-mutant disease responds slower and shallower.", "No approved therapy specific to IgM-related neuropathy.", "Transformation to DLBCL (5-10%...["Indefinite BTKi therapy: cost, toxicity and resistance (BTK C481S).", "CXCR4-mutant disease responds slower and shallower.", "No approved therapy specific to IgM-related neuropathy.", "Transformation to DLBCL (5-10%...
  • FieldBeforeAfter
    burdenMerkel cell carcinoma causes about 3,000 cases per year in the US and rising; median age is ~75; it is roughly 40 times rarer than melanoma but twice as lethal stage for stage."Merkel cell carcinoma causes about 3,000 cases per year in the US and rising; median age is ~75; it is roughly 40 times rarer than melanoma and more likely to spread stage for stage, which is why immunotherapy's dura...
  • FieldBeforeAfter
    burdenSecond most common skin cancer; over one million cases per year in the US; about 2-5% metastasise, but that is still several thousand deaths a year."Second most common skin cancer; over one million cases per year in the US, almost all cured by removal; about 2-5% metastasise, which still amounts to several thousand deaths a year and is where PD-1 immunotherapy no...
  • FieldBeforeAfter
    tldr"Basal cell carcinoma is the most common cancer of all, caused by sun exposure and almost never fatal. Nearly all are removed surgically; the rare advanced cases are treated with drugs that block the hedgehog signalli..."Basal cell carcinoma is the most common cancer of all, caused by sun exposure and almost never life-threatening. Nearly all are removed surgically; the rare advanced cases are treated with drugs that block the hedgeh...
  • FieldBeforeAfter
    stateOfArt["CRS-HIPEC turned PMP from a fatal disease into one with long survival for low-grade histology.", "Grade, not stage, drives therapy: the 2024 randomised trial ended routine chemotherapy for low-grade mucinous carcino...["CRS-HIPEC turned PMP from a disease with no effective treatment into one with long survival for low-grade histology.", "Grade, not stage, drives therapy: the 2024 randomised trial ended routine chemotherapy for low-...
  • FieldBeforeAfter
    summary"Medulloblastoma is an embryonal tumour of the posterior fossa with four consensus molecular subgroups (WNT, SHH, Group 3, Group 4) that differ in age, genetics, metastatic tendency and survival: WNT (~10%, CTNNB1 mut..."Medulloblastoma is an embryonal tumour of the posterior fossa with four consensus molecular subgroups (WNT, SHH, Group 3, Group 4) that differ in age, genetics, metastatic tendency and survival: WNT (~10%, CTNNB1 mut...
    openProblems["Group 3 MYC-amplified and SHH TP53-mutant tumours: survival under 50%.", "Relapse is almost always fatal after craniospinal irradiation.", "Neurocognitive, endocrine and hearing sequelae in survivors.", "Infants: cu...["Group 3 MYC-amplified and SHH TP53-mutant tumours: survival under 50%.", "Relapse after craniospinal irradiation is rarely curable; it is where new approaches are most needed.", "Neurocognitive, endocrine and hearin...
  • FieldBeforeAfter
    tldr"Osteosarcoma is the most common bone cancer, mostly in teenagers. Chemotherapy plus surgery cures about two-thirds when it has not spread, but survival has not improved in 30 years and no new drug has worked in a lar..."Osteosarcoma is the most common bone cancer, mostly in teenagers. Chemotherapy plus surgery cures about two-thirds when it has not spread; because no new drug has beaten that chemotherapy in a large trial in 30 years...
  • FieldBeforeAfter
    openProblems["Diffuse anaplastic and relapsed disease: survival ~50% or lower.", "Global inequity: Wilms is curable, yet most children with it worldwide die.", "Late effects of doxorubicin and radiation in 90% survivors.", "Bilat...["Diffuse anaplastic and relapsed disease: survival ~50% or lower.", "Global inequity: Wilms is curable, yet most children with it worldwide lack access to the treatment that cures it; adapted regimens (SIOP PODC) are...
  • FieldBeforeAfter
    tldr"An eye cancer of infants caused by loss of the RB1 gene, the first tumour-suppressor gene ever found. In rich countries almost every child survives and most eyes are saved by chemotherapy delivered through the eye's ..."An eye cancer of infants caused by loss of the RB1 gene, the first tumour-suppressor gene ever found. In rich countries almost every child survives and most eyes are saved by chemotherapy delivered through the eye's ...
    summary"Retinoblastoma arises from biallelic loss of RB1 in developing retinal cells (Knudson's two-hit hypothesis, 1971; RB1 cloned 1986), or rarely from MYCN amplification with intact RB1. Heritable disease (~40%, germline..."Retinoblastoma arises from biallelic loss of RB1 in developing retinal cells (Knudson's two-hit hypothesis, 1971; RB1 cloned 1986), or rarely from MYCN amplification with intact RB1. Heritable disease (~40%, germline...
    standardOfCare[ { setting: "Advanced unilateral (group E, no vision potential)", approach: "Primary enucleation with long optic nerve segment; adjuvant chemotherapy (VEC) for high-risk pathology; orbital implant.", refs: ["vi...[ { setting: "Advanced unilateral (group E, no vision potential)", approach: "Primary enucleation with long optic nerve segment; adjuvant chemotherapy (VEC) for high-risk pathology; orbital implant.", refs: ["vi...
    stateOfArt["Intra-arterial chemotherapy saves eyes that would have been removed, with globe salvage ~70-90% in group D and few systemic effects.", "Radiation has been almost eliminated because of second cancers in RB1 carriers....["Intra-arterial chemotherapy saves eyes that would have been removed, with globe salvage ~70-90% in group D and few systemic effects.", "Radiation has been almost eliminated because of second cancers in RB1 carriers....
    openProblems["Late diagnosis and death in low-income countries; paediatric ophthalmology access.", "Second primary cancers in RB1 carriers across life.", "Vision outcomes after eye salvage.", "Metastatic and CNS disease."]["Late diagnosis in low-income countries; paediatric ophthalmology access is the lever.", "Second primary cancers in RB1 carriers across life.", "Vision outcomes after eye salvage.", "Metastatic and CNS disease."]
  • FieldBeforeAfter
    tldr"Cancer found already spread, where doctors cannot find where it started. Most cases are treated with general-purpose chemotherapy and do poorly; molecular tests to guess the origin or find a drug target are slowly ch..."Cancer found already spread, where doctors cannot find where it started. Genomic profiling finds a drug target in about a third of cases and tumour-agnostic approvals apply directly; the rest still rely on general-pu...
  • FieldBeforeAfter
    openProblems["Radiation late effects in a disease cured young.", "Western access to PD-1 inhibitors studied in Asia; regulatory lag.", "EBV-targeted therapy (vaccines, EBV-specific T cells) still investigational.", "Distant metas...["Radiation late effects in a disease cured young.", "Western access to PD-1 inhibitors studied in Asia; regulatory lag.", "EBV-targeted therapy (vaccines, EBV-specific T cells) still investigational.", "Distant metas...
  • FieldBeforeAfter
    openProblems["Access to effective chemotherapy and ART-linked cancer care in sub-Saharan Africa.", "KS in people with suppressed HIV and normal CD4 counts (unexplained).", "No antiviral therapy targets latent KSHV.", "Endemic chi...["Access to effective chemotherapy and ART-linked cancer care in sub-Saharan Africa.", "KS in people with suppressed HIV and normal CD4 counts (unexplained).", "No antiviral therapy targets latent KSHV.", "Endemic chi...
  • FieldBeforeAfter
    tldrEngineered immune cells delivered directly into the brain or spinal fluid. Some children with an incurable brainstem tumour have had striking, if temporary, responses.Engineered immune cells delivered directly into the brain or spinal fluid. Some children with diffuse midline glioma, a brainstem tumour with no curative treatment, have had striking, if temporary, responses.
  • FieldBeforeAfter
    tldrA single change in a histone protein that defines the most lethal childhood brain tumour, and now the target of the first approved drug for it.A single change in a histone protein that defines diffuse midline glioma, the childhood brain tumour with the fewest treatment options, and now the target of the first approved drug for it.
  • FieldBeforeAfter
    tldrHigh-grade serous ovarian carcinoma is the most common and most lethal type of ovarian cancer; it actually starts in the fallopian tube and almost always has a broken TP53 gene."High-grade serous ovarian carcinoma is the most common type of ovarian cancer and the one most often found late; it actually starts in the fallopian tube and almost always has a broken TP53 gene, and it is the type P...
    summary"About 70% of ovarian cancer deaths. Near-universal TP53 mutation, ~50% homologous recombination deficiency (including ~20% BRCA1/2), extensive copy-number instability, few recurrent targetable mutations. Arises from ..."The type behind about 70% of ovarian cancer deaths, and the one where maintenance therapy has changed the most. Near-universal TP53 mutation, ~50% homologous recombination deficiency (including ~20% BRCA1/2), extensi...
  • changedKITtargetall changes
    FieldBeforeAfter
    tldrKIT mutation is the driver behind most gastrointestinal stromal tumours, and the reason imatinib turned a lethal sarcoma into a chronic disease.KIT mutation is the driver behind most gastrointestinal stromal tumours, and the reason imatinib turned a sarcoma with a median survival of about a year into a chronic disease.
  • FieldBeforeAfter
    tldrCancer that has spread from where it started to distant parts of the body, travelling through the blood or lymph. Metastasis is what makes most cancers deadly."Cancer that has spread from where it started to distant parts of the body, travelling through the blood or lymph. Metastasis is why staging scans look at the whole body, and the setting in which most new cancer drugs...
Sources: official-website links on a further thirty companiesJude Gomilaf7782c9f5f
  • FieldBeforeAfter
    linksabsent[{ label: "Official website", url: "https://www.jnj.com" }]
  • FieldBeforeAfter
    linksabsent[{ label: "Official website", url: "https://www.jazzpharma.com" }]
  • FieldBeforeAfter
    linksabsent[{ label: "Official website", url: "https://www.iovance.com" }]
  • FieldBeforeAfter
    linksabsent[{ label: "Official website", url: "https://www.legendbiotech.com" }]
  • changedLantheuscompanyall changes
    FieldBeforeAfter
    linksabsent[{ label: "Official website", url: "https://www.lantheus.com" }]
  • FieldBeforeAfter
    linksabsent[{ label: "Official website", url: "https://itm-radiopharma.com" }]
  • FieldBeforeAfter
    linksabsent[{ label: "Official website", url: "https://www.intuitive.com" }]
  • changedInsighteccompanyall changes
    FieldBeforeAfter
    linksabsent[{ label: "Official website", url: "https://www.insightec.com" }]
  • changedkaiko.aicompanyall changes
    FieldBeforeAfter
    linksabsent[{ label: "Official website", url: "https://www.kaiko.ai" }]
  • FieldBeforeAfter
    linksabsent[{ label: "Official website", url: "https://www.lila.ai" }]
  • FieldBeforeAfter
    linksabsent[{ label: "Official website", url: "https://www.latentlabs.com" }]
  • FieldBeforeAfter
    linksabsent[{ label: "Official website", url: "https://www.hengrui.com" }]
  • FieldBeforeAfter
    linksabsent[{ label: "Official website", url: "https://www.macrogenics.com" }]
  • changedIncytecompanyall changes
    FieldBeforeAfter
    linksabsent[{ label: "Official website", url: "https://www.incyte.com" }]
  • FieldBeforeAfter
    linksabsent[{ label: "Official website", url: "https://www.karyopharm.com" }]
  • changedIpsencompanyall changes
    FieldBeforeAfter
    linksabsent[{ label: "Official website", url: "https://www.ipsen.com" }]
  • changedLonzacompanyall changes
    FieldBeforeAfter
    linksabsent[{ label: "Official website", url: "https://www.lonza.com" }]
  • FieldBeforeAfter
    linksabsent[{ label: "Official website", url: "https://www.jubilantradiopharma.com" }]
  • FieldBeforeAfter
    linksabsent[{ label: "Official website", url: "https://www.leicabiosystems.com" }]
  • FieldBeforeAfter
    linksabsent[{ label: "Official website", url: "https://indicalab.com" }]
  • changedLimbus AIcompanyall changes
    FieldBeforeAfter
    linksabsent[{ label: "Official website", url: "https://limbus.ai" }]
  • FieldBeforeAfter
    linksabsent[{ label: "Official website", url: "https://www.komodohealth.com" }]
  • changedMedablecompanyall changes
    FieldBeforeAfter
    linksabsent[{ label: "Official website", url: "https://www.medable.com" }]
  • FieldBeforeAfter
    linksabsent[{ label: "Official website", url: "https://www.usoncology.com" }]
  • changedIQVIAcompanyall changes
    FieldBeforeAfter
    linksabsent[{ label: "Official website", url: "https://www.iqvia.com" }]
  • changedIndivumedcompanyall changes
    FieldBeforeAfter
    linksabsent[{ label: "Official website", url: "https://www.indivumed.com" }]
  • changedLabcorpcompanyall changes
    FieldBeforeAfter
    linksabsent[{ label: "Official website", url: "https://www.labcorp.com" }]
  • FieldBeforeAfter
    linksabsent[{ label: "Official website", url: "https://www.elekta.com/products/oncology-informatics/" }]
Sources: official-website links on thirty more companiesJude Gomilad1f1037d6e
Sources: official-website links on the remaining institutions and thirty more companiesJude Gomila1fcb3c8eab
Sources: official-website links on thirty more institutions and thirty companiesJude Gomila708b8acc4f
Sources: official-website link on thirty institutions that had noneJude Gomilaa1202cfd43
Sources: BILCAP registry and publication links; official-website source on nineteen companiesJude Gomilabfc8b4e2d8
  • FieldBeforeAfter
    linksabsent[{ label: "Official website", url: "https://www.avenzotx.com" }]
  • FieldBeforeAfter
    linksabsent[{ label: "Official website", url: "https://www.10xgenomics.com" }]
  • changedArteracompanyall changes
    FieldBeforeAfter
    linksabsent[{ label: "Official website", url: "https://artera.ai" }]
  • changedBioptimuscompanyall changes
    FieldBeforeAfter
    linksabsent[{ label: "Official website", url: "https://www.bioptimus.com" }]
  • changedAignosticscompanyall changes
    FieldBeforeAfter
    linksabsent[{ label: "Official website", url: "https://www.aignostics.com" }]
  • FieldBeforeAfter
    linksabsent[{ label: "Official website", url: "https://www.adaptivebiotech.com" }]
  • changedBILCAPtrialall changes
    FieldBeforeAfter
    linksabsent[{ label: "ISRCTN registry entry (ISRCTN72785446)", url: "https://www.isrctn.com/ISRCTN72785446" }, { label: "Primrose et al., Lancet Oncology 2019", url: "https://doi.org/10.1016/S1470-2045(18)30915-X" }]
  • FieldBeforeAfter
    linksabsent[{ label: "Official website", url: "https://www.blueearthdiagnostics.com" }]
  • FieldBeforeAfter
    linksabsent[{ label: "Official website", url: "https://www.aldevron.com" }]
  • changedAbzenacompanyall changes
    FieldBeforeAfter
    linksabsent[{ label: "Official website", url: "https://www.abzena.com" }]
  • FieldBeforeAfter
    linksabsent[{ label: "Official website", url: "https://www.akoyabio.com" }]
  • changed3DHISTECHcompanyall changes
    FieldBeforeAfter
    linksabsent[{ label: "Official website", url: "https://www.3dhistech.com" }]
  • FieldBeforeAfter
    linksabsent[{ label: "Official website", url: "https://www.agilent.com" }]
  • FieldBeforeAfter
    linksabsent[{ label: "Official website", url: "https://www.bd.com" }]
  • FieldBeforeAfter
    linksabsent[{ label: "Official website", url: "https://www.biolifesolutions.com" }]
  • FieldBeforeAfter
    linksabsent[{ label: "Official website", url: "https://www.baxter.com" }]
  • changedB. Brauncompanyall changes
    FieldBeforeAfter
    linksabsent[{ label: "Official website", url: "https://www.bbraun.com" }]
Primary source links (FDA label via DailyMed) for the last approved products without oneJude Gomila3b662d41c0
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Trastuzumab%20deruxtecan" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Trastuzumab%20emtansine" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Tisotumab%20vedotin" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Telisotuzumab%20vedotin" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Tarlatamab" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Teclistamab" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Tebentafusp" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Zanidatamab" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Zenocutuzumab" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Zongertinib" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Zidesamtinib" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Vepdegestrant" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Vorasidenib" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Venetoclax" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Trastuzumab" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Tucatinib" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Vusolimogene%20oderparepvec" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Tisagenlecleucel" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Ziftomenib" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Trastuzumab%20rezetecan" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Trastuzumab%20biosimilars" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Tamoxifen" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Zanubrutinib" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Tremelimumab" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Trabectedin" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Tivozanib" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Vimseltinib" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Topotecan" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Vandetanib" }]
Primary source links (FDA label via DailyMed) for a fifth batch of approved productsJude Gomilaad64caf371
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Sacituzumab%20govitecan" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Relatlimab" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Satricabtagene%20autoleucel" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Sotorasib" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Selpercatinib" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Talazoparib" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Ribociclib" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Relacorilant" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Revumenib" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Talimogene%20laherparepvec" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Quizartinib" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Tagraxofusp" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Pyrotinib" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Rituximab" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Sonrotoclax" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Tafasitamab" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Selinexor" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Progestins" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Sorafenib" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Talquetamab" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Somatostatin%20analogues" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Sunitinib" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Repotrectinib" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Pralsetinib" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Rucaparib" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Relugolix" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Radium-223%20dichloride" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Ripretinib" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Serplulimab" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Radioactive%20iodine" }]
Primary source links (FDA label via DailyMed) for a fourth batch of thirty approved productsJude Gomila9cbd69eefa
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Mirvetuximab%20soravtansine" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Pembrolizumab" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Nivolumab" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Piflufolastat%20F-18" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Osimertinib" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Olaparib" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Niraparib" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Palbociclib" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Paclitaxel" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Obecabtagene%20autoleucel" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Ponatinib" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Midostaurin" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Olutasidenib" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Pertuzumab" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Neratinib" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Margetuximab" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Nonavalent%20HPV%20vaccine" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Pemigatinib" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Pirtobrutinib" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Obinutuzumab" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Polatuzumab%20vedotin" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Mosunetuzumab" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Odronextamab" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Pemetrexed" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Naxitamab" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Pegylated%20liposomal%20doxorubicin" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Pazopanib" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Nirogacestat" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Nogapendekin%20alfa%20inbakicept" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Nadofaragene%20firadenovec" }]
Primary source links (FDA label via DailyMed) for a third batch of thirty approved productsJude Gomila925a04b429
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Loncastuximab%20tesirine" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Gemtuzumab%20ozogamicin" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Ipilimumab" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Glofitamab" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Lifileucel" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Lutetium-177%20vipivotide%20tetraxetan" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Lutetium-177%20dotatate" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Lorlatinib" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Inavolisib" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Gedatolisib" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Imatinib" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Inotuzumab%20ozogamicin" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Gilteritinib" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Ivosidenib" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Lapatinib" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Fulvestrant" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Imlunestrant" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Goserelin" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Ibrutinib" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Lisocabtagene%20maraleucel" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Lenalidomide" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Isatuximab" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Idecabtagene%20vicleucel" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Linvoseltamab" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Lazertinib" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Letrozole" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Gallium-68%20gozetotide" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Lenvatinib" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Ifosfamide" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Lurbinectedin" }]
Primary source links (FDA label via DailyMed) for thirty more approved productsJude Gomila08f191a505
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Datopotamab%20deruxtecan" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Enfortumab%20vedotin" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Disitamab%20vedotin" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Durvalumab" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Dostarlimab" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Cemiplimab" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Ciltacabtagene%20autoleucel" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Encorafenib" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Elacestrant" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Carboplatin" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Dasatinib" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Decitabine" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Enasidenib" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Exemestane" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Cisplatin" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Epcoritamab" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Cobimetinib" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Carfilzomib" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Daratumumab" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Elranatamab" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Dinutuximab/%20dinutuximab%20beta" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Eflornithine" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Everolimus" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Dabrafenib" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Enzalutamide" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Darolutamide" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Docetaxel" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Flotufolastat%20F-18" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Doxorubicin" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Erdafitinib" }]
Primary source links (FDA label via DailyMed) for thirty approved products that had noneJude Gomilae03f56897d
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Brentuximab%20vedotin" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Belantamab%20mafodotin" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Atezolizumab" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Blinatumomab" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Amivantamab" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Axicabtagene%20ciloleucel" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Afamitresgene%20autoleucel" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Adagrasib" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Abemaciclib" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Capivasertib" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Belzutifan" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Asciminib" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Azacitidine" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Camizestrant" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Alpelisib" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Cadonilimab" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Acalabrutinib" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Bevacizumab" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Binimetinib" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Bortezomib" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Alectinib" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Capmatinib%20%26%20tepotinib" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Avutometinib" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Abiraterone%20acetate" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Apalutamide" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Cabazitaxel" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Axitinib" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Cabozantinib" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Avapritinib" }]
  • FieldBeforeAfter
    linksabsent[{ label: "FDA label (DailyMed)", url: "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Avelumab" }]
Fourteen orphan products now linked from their targets and cancers (ALK, EGFR, ROS1, ER, FOLR1 inhibitors and tracers; myeloma, prostate, glJude Gomila91a4bba51c
Fix: Wikipedia link belongs on the hydrazone glossary term, not the linker registry rowJude Gomila504f15547c
Glossary: Wikipedia links for thirty terms (hallmarks, regulatory, ADC chemistry, endpoints); calendar entry without an em-dashJude Gomila3c0138f0f0

Data: history/index.json, one file per record at /history/<id>.json. See also changelog, corrections, audit.